Search For "covid 19 vaccine candidate"
AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin
Updated : 5 years, 5 months ago IST
New Delhi [India], December 24 (ANI): The All India Institute of Medical Sciences (AIIMS) based in New Delhi on Thursday invited volunteers for the Phase III clinical trial of the indigenously developed COVID-19 vaccine candidate 'Covaxin' for which it is one of the sites.
Read More
Bharat Biotech, Ocugen to co-develop Covaxin for United States market
Updated : 5 years, 5 months ago IST
Hyderabad (Telangana) [India], December 22 (ANI): Hyderabad-based Bharat Biotech and US-based biopharmaceutical firm Ocugen Inc on Tuesday announced that they have signed a binding letter of intent (LOI) to co-develop the Indian firm's COVID-19 vaccine candidate--Covaxin-- for the United Sta
Read More
US purchases 100 million additional Moderna Covid19 vaccine
Updated : 5 years, 5 months ago IST
Washington [US], December 12 (ANI): Biotech company Moderna on Friday (local time) announced that the US government will purchase an additional 100 million doses of its Covid-19 vaccine candidate, thus bringing its confirmed order commitment to 200 million doses.
Read More
Six COVID vaccine candidates in different clinical trial stage in India, t
Updated : 5 years, 5 months ago IST
New Delhi [India], December 8 (ANI): Union Health Secretary Rajesh Bhushan on Tuesday said that there are six COVID-19 vaccine candidates in different clinical trial stages being developed by various manufacturers in India.
Read More
Two weeks after getting first Covaxin trial shot in Haryana, Anil Vij test
Updated : 5 years, 5 months ago IST
New Delhi [India], December 5 (ANI): Haryana Home Minister Anil Vij, who received the first dose of Bharat Biotech's COVID-19 vaccine candidate, Covaxin, during its Phase-III trial in the state two weeks ago, on Saturday said that he has tested positive for the virus.
Read More
Moderna to request Emergency use authorisation, its vaccine 100% effective
Updated : 5 years, 5 months ago IST
Washington [US], November 30 (ANI): US biotech company Moderna on Monday announced that it plans to request an Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) and conditional approval from the European Medicines Agency (EMA) after the final results from a lat
Read More
No correlation of vaccine trial with Chennai volunteer's side effect claim
Updated : 5 years, 6 months ago IST
New Delhi [India], November 29 (ANI): After a Chennai-based man claimed that he suffered neurological and psychological side effects after taking a shot of COVID-19 vaccine candidate Covishield during the human trial, being conducted by Serum Institute of India's (SII), the Pune-based com
Read More
PM Modi visits Bharat Biotech vaccine facility, Zydus Biotech Park
Updated : 5 years, 6 months ago IST
Hyderabad (Telangana) [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday visited the manufacturing facility of Bharat Biotech International Limited (BBIL) in Telangana to review the development of its 'Covaxin' Covid-19 vaccine candidate.
Read More
PM Modi concludes Zydus Biotech Park visit, next stop Bharat Biotech facil
Updated : 5 years, 6 months ago IST
Ahmedabad (Gujarat) [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday concluded his visit to Zydus Biotech Park in Ahmedabad after reviewing the development of COVID-19 vaccine candidate ZyCOV-D.
Read More
Sola Civil Hospital in Ahmedabad begins Phase-3 trial of Covaxin
Updated : 5 years, 6 months ago IST
Ahmedabad (Gujarat) [India], November 27 (ANI): The Phase-3 trial of COVID-19 vaccine candidate Covaxin begun with five volunteers at Sola Civil Hospital in Ahmedabad on Thursday.
Read More
Pfizer, BioNTech to submit to FDA for emergency use authorisation for thei
Updated : 5 years, 6 months ago IST
Washington [US], November 20 (ANI): American drug giant Pfizer and German laboratory BioNTech on Friday said that they will be submitting to the US Food and Drug Administration for emergency use authorisation for their COVID-19 vaccine candidate.
Read More
Hoping to get 1000 volunteers for Covaxin trial, says PGIMS V-C
Updated : 5 years, 6 months ago IST
Rohtak (Haryana) [India], November 19 (ANI): Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, hopes to get 1,000 healthy volunteers by Thursday for the third-phase trial of Bharat Biotech's COVID-19 vaccine candidate, Covaxin, that will begin from F
Read More